Press release
Parkinson's Disease Therapeutic Market Growth and Restrain Factors Analysis Report Exclusive Report on Current Trends and Future Insights
According to the latest research by InsightAce Analytic, the Global Parkinson's Disease Therapeutic Market is valued at US$ 4.22 Bn in 2023, and it is expected to reach US$ 6.51 Bn by 2031, with a CAGR of 5.7% during the forecast period of 2024-2031.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2587
Parkinson's disease (PD) is a progressive and debilitating neurological disorder that primarily affects motor function. Current therapeutic approaches focus on symptom management and enhancing patients' quality of life. The market for Parkinson's disease treatment is experiencing growth due to heightened awareness and earlier diagnosis of the condition. Advances in diagnostic methodologies-such as high-resolution imaging and the identification of reliable biomarkers-are facilitating timely intervention, thereby improving treatment outcomes.
Furthermore, increased investments in research and development by pharmaceutical companies and government agencies are driving innovation in therapeutic options. Strategic collaborations between biotechnology firms and academic institutions are accelerating drug discovery and the development of novel therapies. Additionally, the integration of digital health solutions, such as wearable monitoring devices and telemedicine platforms, is enhancing disease management and supporting patient adherence to treatment protocols, contributing to sustained market expansion.
List of Prominent Players in the Parkinson's Disease Therapeutic Market:
• Teva Pharmaceutical Industries Ltd.,
• Novartis AG
• GlaxoSmithKline Plc.
• AbbVie Inc.
• Merck & Co. Inc.,
• Zydus Cadila
• Dr. Reddy's
• Sun Pharmaceutical Industries Ltd.
• Cipla Inc.
• Boehringer Ingelheim International GmbH
• Denali Therapeutics Inc.
• Biogen Inc.
• Prevail Therapeutics
• Eli Lilly and Company
• Voyager Therapeutics.
• Intas Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• Amneal Pharmaceuticals
• Aurobindo Pharma Limited
• Accord Healthcare Ltd.
Market Dynamics:
Drivers-
The global rise in the prevalence of Parkinson's disease (PD) is a key factor propelling the growth of the therapeutic market. Enhanced awareness and the advancement of diagnostic tools have led to earlier detection of PD, thereby increasing the demand for effective treatment options. The availability of diverse therapeutic approaches, tailored to various stages and severities of the disease, is further supporting improved patient outcomes and expanding the market base. In addition, the integration of artificial intelligence (AI) and machine learning technologies into drug discovery and development is transforming the industry.
Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2587
Challenges:
A key challenge facing the Parkinson's disease therapeutics market is the declining rate of regulatory approvals for new drugs. This trend restricts the introduction of innovative therapies, limiting treatment options for patients and healthcare professionals. The lack of newly approved treatments may result in reduced competition, potentially increasing the cost of existing therapies. Consequently, this stagnation in drug development hinders advancements in care quality and impedes efforts to address the complex needs of individuals living with Parkinson's disease.
Regional Trends:
North America leads the global Parkinson's disease therapeutics market, supported by a high prevalence of the disease, particularly among the ageing population. The United States, in particular, benefits from a robust healthcare infrastructure and widespread awareness initiatives, contributing to significant market growth. Europe also holds a substantial share, driven by a strong economic base, increased adoption of innovative treatment strategies, and proactive initiatives by key industry players. Moreover, strategic collaborations among major companies are enhancing market penetration across the region, creating new growth opportunities in the global Parkinson's disease therapeutics landscape.
Recent Developments:
• In March 2024, Sanofi and Cipla have formed an exclusive collaboration to distribute and promote Sanofi India's Central Nervous System (CNS) product range in India. Under this collaboration, Cipla will assume the responsibility of distributing Sanofi India's six CNS brands, which includes Frisium®, a prominent brand in the anti-epileptic drug field.
• In Oct 2022, Biogen and Denali Therapeutics commenced the Phase 3 LIGHTHOUSE Study in Parkinson's Disease linked to LRRK2 Pathogenic Mutations. The main objective of the LIGHTHOUSE trial was to measure the duration until proven deterioration, evaluated using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), during the treatment term of up to 180 weeks.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2587
Segmentation of Parkinson's Disease Therapeutic Market-
By Drugs
• Carbidopa-levodopa
• Dopamine agonists
• Mao-b inhibitors
• COMT inhibitors
• Anticholinergics
• Others
By Distribution Channel-
• Hospital pharmacy
• Retail pharmacy
• Online pharmacy
By Brand
• Branded
• Generics
By Route of Administration
• Oral,
• Injectable,
• Intestinal Infusion,
• Subcutaneous
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get More Information: @
https://www.insightaceanalytic.com/report/parkinsons-disease-therapeutic-market/2587
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson's Disease Therapeutic Market Growth and Restrain Factors Analysis Report Exclusive Report on Current Trends and Future Insights here
News-ID: 4298803 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Artisanal Flavors Beverages Market Exclusive Report on Current Trends and Future …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Artisanal Flavors Beverages Market"-, By Product Type (Plant-Based Milk, Plant-Based Juices, RTD Tea & Coffee, Others), By Source (Nuts, Grains, Legumes, Fruits & Vegetables, Others), By Distribution Channel (Online, Offline), and Global Forecasts, 2024-2034 And Segment Revenue and Forecast To 2034."
The Artisanal Flavors Beverages Market Size is developed with an 8.8% CAGR during the…
Antimicrobial Irrigation System Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Antimicrobial Irrigation System Market - (By Type (Wound Cleanser, Debridement Device), By Application (Traumatology, Surgery, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Antimicrobial Irrigation System Market is predicted to grow with a CAGR of 4.21% during the forecast period of 2024-2031.
Request For Free…
AI in Water and Sanitation Market Report- Expansive Coverage on the Profit Sourc …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Water and Sanitation Market - (By Type (Machine Learning Algorithms, Natural Language Processing (NLP) Systems, Computer Vision Systems, Expert Systems, Neural Networks), By Application (Water Quality Monitoring, Water Leak Detection, Wastewater Treatment Optimization, Water Supply Management, Sanitation and Waste Management) By End-User (Municipalities and Water Authorities, Industrial Sector (Factories, Manufacturing, etc.), Residential and…
AI in Childcare and Parenting Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Childcare and Parenting Market - (By Type (AI-Enhanced Toys and Games, AI-Powered Educational Apps and Content, AI-Driven Virtual Assistants for Parenting, AI-Enabled Monitoring Devices and Wearables, AI-Integrated Learning Systems for Children), By Application (Child Development and Learning Enhancement, Parental Support and Guidance, Safety and Security Solutions, Remote Monitoring and Supervision, Personalized Learning and…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…
